Copyright
©The Author(s) 2004. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 15, 2004; 10(18): 2661-2665
Published online Sep 15, 2004. doi: 10.3748/wjg.v10.i18.2661
Published online Sep 15, 2004. doi: 10.3748/wjg.v10.i18.2661
Effect of lamivudine treatment on plasma levels of transforming growth factor β1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B
Robert Flisiak, Haza Al-Kadasi, Jerzy Jaroszewicz, Danuta Prokopowicz, Department of Infectious Diseases, Medical University, Bialystok, Poland
Iwona Flisiak, Department of Dermatology and Venereology, Medical University, Bialystok, Poland
Author contributions: All authors contributed equally to the work.
Correspondence to: Robert Flisiak, MD, Ph.D, Professor, Department of Infectious Diseases, Liver Unit, Medical University of Bialystok, 15-540 Bialystok, Zurawia str., 14, Poland. flisiakr@priv.onet.pl
Telephone: +48-85-7409481 Fax: +48-85-7434613
Received: January 15, 2004
Revised: January 23, 2004
Accepted: March 4, 2004
Published online: September 15, 2004
Revised: January 23, 2004
Accepted: March 4, 2004
Published online: September 15, 2004
Core Tip